Shares of Apogee Therapeutics Inc. (APGE) have gained 24.1% over the past four weeks to close the last trading session at 40.12,buttherecouldstillbeasolidupsideleftinthestockifshort−termpricetargetsofWallStreetanalystsareanyindication.Goingbythepricetargets,themeanestimateof93.88 indicates a potential upside of 134%.The average comprises eight short-term price targets ranging from a low of 78toahighof116, with a standard deviation of $11.05. While the lowest estimat ...